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Abstract
Introduction: The number of patients requiring prolonged mechanical ventilation (PMV) is likely to increase.
Transferring patients to specialised weaning units may improve outcomes and reduce costs. The aim of this study
was to establish the incidence and outcomes of PMV in a UK administrative health care region without a
dedicated weaning unit, and model the potential impact of establishing a dedicated weaning unit.
Methods: A retrospective cohort study was undertaken using a database of admissions to three intensive care
units (ICU) in a UK region from 2002 to 2006. Using a 21 day cut-off to define PMV, incidence was calculated using
all ICU admissions and ventilated ICU admissions as denominators. Outcomes for the PMV cohort (mortality and
hospital resource use) were compared with the non-PMV cohort. Length of ICU stay beyond 21 days was used to
model the effect of establishing a weaning unit in terms of unit occupancy rates, admission refusal rates, and
healthcare costs.
Results: Out of 8290 ICU admission episodes, 7848 were included in the analysis. Mechanical ventilation was
required during 5552 admission episodes, of which 349 required PMV. The incidence of PMV was 4.4 per 100 ICU
admissions, and 6.3 per 100 ventilated ICU admissions. PMV patients used 29.1% of all general ICU bed days, spent
longer in hospital after ICU discharge than non-PMV patients (median 17 vs 7 days, P < 0.001) and had higher
hospital mortality (40.3% vs 33.8%, P = 0.02). For the region, in which about 70 PMV patients were treated each year,
a weaning unit with a capacity of three beds appeared most cost efficient, resulting in an occupancy rate of 73%,
admission refusal rate at 21 days of 36%, and potential cost saving of £344,000 (€418,000) using UK healthcare tariffs.
Conclusions: One in every sixteen ventilated patients requires PMV in our region and this group use a substantial
amount of health care resource. Establishing a weaning unit would potentially reduce acute bed occupancy by 8-
10% and could reduce overall treatment costs. Restructuring the current configuration of critical care services to
introduce weaning units should be considered if the expected increase in PMV incidence occurs.
Introduction
The requirement for a period of mechanical ventilation
(MV) usually mandates admission to an ICU [1]. Most
patients require short periods of respiratory support, but
a minority require prolonged mechanical ventilation
(PMV), which has been defined as a period of 21 days or
more [2]. This definition is particularly relevant in the
US health system because, due to financial drivers pri-
marily, such patients are often subsequently transferred
to long-term acute care (LTAC) facilities or specialised
weaning units. The number of patients requiring MV is
predicted to increase, in particular those who are elderly
or with comorbidities, leading to a likely increase in the
incidence of PMV [3]. Trends in the numbers of patients
requiring PMV are of interest to health service planners
because they consume a disproportionate amount of
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any medium, provided the original work is properly cited.health care resources, and have high illness costs [4,5]. A
recent study using the Medicare database showed a dra-
matic increase in the number of patients admitted to
LTAC facilities in the US between 1997 and 2006, many
of whom will fulfil the criteria for PMV [6]. The limited
available data on patient outcomes indicate considerable
variations between the populations studied [7].
In some countries, specialised weaning units have
been established to manage patients who are stable
except for the requirement for PMV. Potential advan-
tages of these units include an increased focus on
patient-centred rehabilitation, a greater concentration of
management expertise, and improved patient outcomes
[8]. Weaning units are potentially cost-effective because
they require lower staff-to-patient ratios than ICUs [9].
Few weaning units exist in the UK, and LTAC facilities
are not part of the health care model. As a result, most
patients requiring long-term critical care remain in
acute hospitals under the care of intensivists until suc-
cessfully weaned from MV [9]. The UK system is there-
fore well suited to model the potential impact of
weaning units to manage PMV cases.
The aim of this study was to use routinely collected
audit data to establish the incidence of PMV in a health
care administrative region of the UK, to report charac-
teristics and outcomes of the PMV cohort, and to
model the potential impact of establishing a weaning
unit on costs and services.
Materials and methods
Design
We performed a retrospective cohort study using pro-
spectively collected data available in the Scottish Inten-
sive Care Society Audit Group (SICSAG) database [10].
The Local Research Ethics Committee (Lothian
Research Ethics Committee 3) waived the need for for-
mal ethical review. Patient confidentiality was ensured
as the dataset was fully anonymised.
Setting
Our study was based in Lothian Health Board, which
serves a population of 900,000 in South East Scotland.
The region is served by three adult hospitals managed
as a single organisation providing general ICU services
as well as some national and specialist regional services:
neuroscience (including traumatic brain injury), solid
organ transplantation (excluding heart/lung), trauma,
acute liver failure, and complex vascular surgery. Each
hospital has a “closed” adult general mixed medical/sur-
gical ICU with specialist intensive care staff. The num-
ber of funded ICU beds in the region varied from 23 to
26 over the study period [see Additional file 1, Table
S1]. In total, the three ICUs typically manage about
1,100 MV patients per year. Referral patterns for South
East Scotland mean that ICU patients comprise almost
all patients requiring critical care in the geographical
region, as well as some patients from outside the region
for whom national or wider regional specialist services
are provided. Cardiac surgery and coronary care services
are managed in separate units and are not included in
this analysis. Paediatric services are also not considered.
Database
Every patient admission episode to an adult general ICU
in Scotland generates a record that is stored in the SIC-
SAG database [10]. A national validation study showed
that the data quality was of a high standard when com-
pared with clinical case notes, with only a 6% level of
disagreement [11]. All data are entered prospectively by
clinical staff and include demographics, Acute Physiol-
ogy and Chronic Health Evaluation (APACHE) II scor-
ing, and diagnostic data. Organ support data (e.g.
invasive ventilation, renal replacement therapy (RRT),
vasoactive therapy) and presence of a tracheostomy are
entered on a daily basis during an admission episode.
RRT in the three units is usually continuous haemofil-
tration, although intermittent haemodialysis is occasion-
ally provided for more stable patients. Non-invasive
ventilation is available in all units, but is not recorded in
the SICSAG database. Survival status at ICU and hospi-
tal discharge is also recorded.
Patient cohorts
All patient records were extracted from the SICSAG
database from the three ICUs over a five-year period,
from 1 January 2002 to 31 December 2006. The follow-
ing two groups were excluded prior to analysis: patients
under 16 years old and patients transferred between
ICUs with incomplete data for at least one admission
episode. These incomplete admission episodes resulted
from patient transfers to/from ICUs that did not contri-
bute to the Lothian regional dataset.
Variables
Comorbidities were obtained from APACHE II chronic
health evaluation categories. Admission diagnosis was
derived from APACHE III diagnostic categories, with
new groupings created by manual review by one of the
authors (NL) for pneumonia, trauma, and sepsis [see
Additional file 1, Table S2]. Outcome variables were
recorded in the SICSAG dataset. No assumptions were
made regarding missing data, and analyses were under-
taken using a complete-case analysis.
Calculation of PMV incidence
Calculation of incidence requires an agreed numerator and
denominator, and neither are universally agreed when
describing the epidemiology of PMV. For numerator
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analyses given the potential limitations of retrospective
data as detailed below.
Consecutive PMV (consecPMV)
An international consensus defined PMV as at least six
hours of ventilation per day for 21 consecutive days [2].
In the SICSAG database, a ventilated day is defined as
ventilation for any period of time during the preceding
24 hours. For admission episodes in 2005 and 2006, the
number of consecutive days ventilated were available.
For these two years the data enabled us to identify
patients who required at least 21 consecutive days of
MV (or endotracheal tube in situ). We allowed a period
of discontinuation of ventilation of one day or less
within this definition to allow for recording errors or
brief MV free periods. This definition was termed con-
secutive PMV (consecPMV).
Counted PMV (countPMV)
The total number of ventilated days during an ICU stay,
without reference to the number of consecutive venti-
lated days, was available for the entire dataset (2002 to
2006). To maximise information from the available data-
set in analyses, a second measure of PMV was defined
as ventilation for 21 days or more with no reference to
consecutive days ventilated. This definition was termed
counted PMV (countPMV).
For denominator data, we used two different mea-
sures. First, all ICU admissions irrespective of MV status
during ICU stay (ICUtotal); second, all ICU admissions
who required MV at any time during ICU stay (ICU-
vent). Trends in the annual incidence of PMV were cal-
culated for the study period (2002 to 2006) using
countPMV as the numerator, and both measures of
denominator. In addition to these measures, we under-
took a sensitivity analysis in which we included the
group with incomplete admission episodes to recalculate
incidence using countPMV as the numerator. We classi-
fied episodes in this group as PMV if the length of hos-
pital stay before or after the index ICU admission made
it possible that ventilation for 21 days or more occurred.
Resource utilisation
The number of bed-days used by the PMV population
was calculated as a proportion of total funded level
three bed-days in the three Lothian ICUs over the study
period. A level three bed is one in which a patient
receives MV and/or multi-organ support. Annual esti-
mates of number of funded ICU bed-days in Lothian
were obtained from local service managers.
Modelling a regional weaning unit
We limited modelling to data from the years 2005 and
2006 because consecutive daily organ support data were
available for this subgroup. Four different hypothetical
weaning units were modelled using different admission
criteria (see Table 1). In all cases we used consecPMV
as the numerator.
Criteria were chosen after discussion with intensive
care clinicians locally and a review of the literature,
acknowledging that weaning units were unlikely to
admit patients still requiring cardiovascular support, and
may not be able to provide RRT. In general, unit A
represented the most stable patients requiring only ven-
tilatory support who were likely to have a low risk of
clinical deterioration. In contrast unit D represented
patients requiring ongoing renal support in whom cardi-
ovascular support was only recently discontinued, and
who may have been at greater risk of clinical deteriora-
tion. Units B and C were modelled to include patients
at intermediate levels of risk.
For modelling, the analyses were undertaken using syn-
tax programming in the statistical software package SPSS
(SPSS Inc., Chicago, IL, USA), and the results were cross-
checked manually for unit A in a spreadsheet package (not
shown). The date of eligibility for each PMV patient for
each of the four hypothetical units was determined,
excluding patients who never reached eligibility criteria. In
this eligible patient group, no patient had more than one
admission episode. For each hypothetical unit, baseline
characteristics of eligible patients were described, together
with ultimate hospital outcome. We used the remaining
length of stay in ICU after eligibility from individual level
patient data to calculate occupancy rates, varying capacity
from one to eight beds for each of the four weaning units.
We also estimated the likely refusal rates for admission as
a result of inadequate capacity by assessing weaning unit
bed availability on the day that a patient became eligible
for admission to the weaning unit. If the unit was full on
this day, this was counted as a refusal. Costs were calcu-
lated using a top-down approach which included physician
and staff costs. Prices were converted from UK£ to euros
(€) using the Organisation for Economic Co-operation and
Table 1 Eligibility criteria for four models of weaning units
Unit A Unit B Unit C Unit D
Minimum period of consecutive ventilation 21 days 21 days 21 days 21 days
Minimum period free from RRT prior to transfer 7 days 2 days RRT allowed RRT allowed
Minimum period free from vasoactive treatment prior to transfer 7 days 2 days 7 days 2 days
RRT, renal replacement therapy.
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£0.822292 [12]. An ICU bed-day was assumed to cost
€1,690 per day (£1,390 published UK National Health Ser-
vice (NHS) tariff 2009/10) [13], and a weaning unit bed
around half this value [9]. The reduced cost of weaning
unit beds is due to the expected lower staffing ratios
required. A sensitivity analysis was undertaken varying the
cost of a weaning unit bed from 50% to 100% of the cost
of an ICU bed. The model assumed that staffing an unoc-
cupied bed in the weaning unit would accrue the same
cost as an occupied bed. In addition, eligible patients
would only be transferred once a bed became available.
Statistical analysis
All analyses were undertaken using SPSS v14. Patient
characteristics were presented as number and percen-
tage, mean and standard deviation (SD), and/or median
and interquartile range (IQR). Both mean and median
values were reported for continuous variables with
skewed distributions, which were important in reporting
resource use, for example length of ICU stay. Character-
istics were described for PMV and non-PMV groups,
and compared with the following tests: t-test for
normally distributed data, Mann-Whitney U test
for non-normally distributed data, and chi-squared test
for categorical variables. Trends were analysed using
chi-squared test for trend for categorical variables. The
association between PMV status and diagnostic category
was assessed using relative risk, although only those
with a P value less than 0.0004 were considered to be
significant to correct for multiple comparisons. Confi-
dence intervals (CI) for incidence rates were derived
using the Poisson distribution [14]. A significance level
of 5% was used for analyses and 95% CI were presented
(unless stated).
Results
Between 2002 and 2006, there were 8,290 admission epi-
sodes to the three ICUs, of which 257 (3.1%) were
excluded according to pre-defined criteria. Merging
multiple episodes for the same patient reduced the
number of patient episodes by 185, leaving 7,848 admis-
sion episodes, which constituted the study population
(Figure 1). Baseline characteristics for patients with
incomplete admission episodes (n =2 0 8 )h a ds i m i l a r
baseline characteristics to the study population although
a higher proportion required PMV (11.1% vs 4.4%) [see
Additional file 1, Table S3].
Comparison of PMV and non-PMV groups
Patients who required PMV (defined as countPMV)
when compared with non-PMV patients for the years
2002 to 2006 were older, more likely to be non-surgical
admissions, had higher overall severity of illness on
admission, and worse oxygenation on day one, but had
fewer recorded comorbidities (Table 2). Pneumonia, sep-
tic shock, and trauma were among the most common
five reasons for admission in both groups. However,
only five ICU admission diagnostic categories were asso-
ciated with a significantly higher risk of PMV (P <
0.0004 for all comparisons): Guillain-Barré syndrome
(relative risk (RR) = 12.2), pancreatitis (RR = 4.6), acute
respiratory distress syndrome (RR = 4.0), pneumonia
(RR = 3.4), and septic shock (RR = 2.1).
A comparison of outcomes for PMV and non-PMV
groups is shown in Table 2. PMV patients had a non-
significant increase in ICU mortality (absolute difference
= 2.9%, 95% CI -1.9% to 8.3%, P = 0.23), which reached
statistical significance at hospital discharge (absolute dif-
ference = 6.5%, 95% CI = 1.1% to 12.2%, P =0 . 0 2 ) .
PMV patients had longer post-ICU hospital stays than
non-PMV patients (P < 0.001). Patterns of discharge
from the acute hospital were similar for the two groups
(P = 0.06), with a high proportion of PMV patients dis-
charged to their own residence from the acute hospital
(89%) and small numbers being transferred to rehabilita-
tion or long-term care facilities (11%).
PMV incidence and resource use
The incidence of PMV calculated using different defini-
tions of numerator and denominator is shown in
Table 3. For countPMV (data 2002 to 2006) the inci-
dence was 4.4 per 100 ICU admissions using all admis-
sions as the denominator and 6.3 per 100 ventilated
ICU admissions. For consecPMV (data 2005 to 2006)
the incidence was 3.7 per 100 admissions, which com-
pared with an incidence of 3.9 per 100 admissions when
countPMV was calculated for the same period.
Admission episodes to 
ICU (2002 to 2006) 
n=8290
Excluded Episodes
Aged under 16 n=49
Incomplete admission episodes 
n=208 
Records removed through merging 
inter-ICU transfers n=185
Study population
n=7848
Non-PMV cohort
Ventilated for <21 days
n=7499
PMV cohort
Ventilated for 21 days
n=349
Figure 1 Flow diagram indicating derivation of study
population. PMV, prolonged mechanical ventilation.
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n*
PMV Non-PMV PMV Non-PMV P value
Age mean (SD) 349 7,499 59.6 (15.2) 56.9 (18.1) 0.001
Sex n (% female) 349 7,499 148 (42.4) 3,218 (42.9) 0.86
Days in hospital before ICU admission <0.001
a
Mean (SD) 5.9 (14.0) 3.5 (11.0)
Median (IQR) 1 (0 to 5) 0 (0 to 2)
APACHE II score mean (SD) 307 6,659 21.0 (6.8) 18.8 (8.3) <0.001
CPR in 24 hours before ICU admission n (%) 349 7,499 23 (6.6) 663 (8.8) 0.15
Number of co-morbidities n (%) 340 7,228 <0.001
a
None 276 (81.2) 5,317 (73.6)
1 50 (14.7) 1,211 (16.8)
2 or more 14 (4.1) 700 (9.7)
Surgical status n (%) 347 7,463 <0.001
Emergency 52 (15.0) 1,747 (23.4)
Elective 15 (4.3) 893 (12.0)
Non-surgical 280 (80.7) 4,823 (64.6)
Ventilated on day 1 n (%) 341 7,354 312 (91.5) 4,884 (66.4) <0.001
PaO2:FiO2 ratio (mmHg) 334 6,477 <0.001
Mean (SD) 155 (82) 242 (125)
Median (IQR) 139 (93 to 201) 227 (142 to 322)
Tracheostomy placed during admission n (%) 349 7,499 219 (62.8) 470 (6.3) <0.001
Five most common admission diagnoses n (%) 349 7,499 -
Pneumonia - any cause 92 (26.4) 650 (8.7)
Septic shock - any source 39 (11.2) 398 (5.3)
Trauma 22 (6.3) 466 (6.2)
Gastrointestinal perforation 18 (5.2) -
Pancreatitis 18 (5.2) -
Cardiac arrest - 457 (6.1)
Self-inflicted overdose - 401 (5.3)
Length of ICU stay (days) 349 7,499 -
Mean (SD) 37.2 (16.1) 3.8 (4.9)
Median (IQR) 33 (26 to 44) 2 (1 to 5)
Number of days ventilated 349 7,499 -
Mean (SD) 33.2 (14.7) 2.9 (4.2)
Median (IQR) 29 (24 to 38) 1 (0 to 3)
Length of hospital stay after ICU discharge (days) 296 6,709 <0.001
a
Mean (SD) 35 (49) 19 (40)
Median (IQR) 17 (0 to 45) 7 (0 to 20)
Hospital discharge destination of survivors n (%) 179 4,436 0.06
Normal residence 160 (89.4) 4,155 (93.7)
Rehabilitation unit 14 (7.8) 224 (5.0)
Long-term institutional care 5 (2.8) 49 (1.1)
Hospice or equivalent 0 (0) 5 (0.1)
ICU mortality n (%) 317 7,103 83 (26.2) 1,654 (23.3) 0.23
Hospital mortality n (%) 305 6,763 123 (40.3) 2,286 (33.8) 0.02
Readmission episodes are excluded (n = 428) for length of hospital stay, hospital discharge destination, ICU mortality and hospital mortality. *Due to missing
data, n is stated for each variable.
aMann-Whitney U test.
APACHE, Acute Physiology and Chronic Health Evaluation; CPR, cardiopulmonary resuscitation; FiO2, fraction of inspired oxygen; IQR, interquartile range; PaO2,
partial pressure of arterial oxygen in mmHg; PMV, prolonged mechanical ventilation; SD, standard deviation.
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incomplete admission episodes (n = 208) gave a
countPMV incidence of up to 5.8 per 100 ICU admis-
sions (95% CI = 5.3 to 6.3), or 8.8 per 100 ventilated
ICU admissions (95% CI = 8.0 to 9.6).
Over the entire study period (2002 to 2006) there
were, on average, 24.4 funded level three ICU beds per
year in the region (Table 1), and there was a mean of 70
PMV cases annually. Mean ICU length of stay per PMV
case was 37.2 days, equating to 29.1% of all funded level
three ICU bed days over the study period.
Modelling a regional weaning unit
Out of 126 patients requiring PMV during the period
2005 to 2006, between 80% (unit A) and 93% (unit D)
were eligible for transfer to the hypothetical weaning
units. Table 4 summarises the eligibility criteria, patient
characteristics, outcomes, and bed-day use of the
cohorts eligible to be admitted to each of the four wean-
ing units. Mortality was lower at ICU discharge and
hospital discharge in unit A, the unit which accepted
more stable patients (no RRT or vasoactive support for
seven days prior to transfer).
The proportion of funded ICU bed-days used by these
cohorts of patients varied from 8.1% to 9.7%, equivalent
to a mean of 2.0 to 2.4 ICU beds occupied per day in
the region over the two-year period. Figure 2 demon-
strates how occupancy and refusal rates changed for
weaning units A to D when capacity was varied from
one to eight beds. For example, a three-bed unit with
eligibility criteria for unit D would have a bed occu-
pancy rate of 72.6%. However, a new admission would
be refused admission on the day eligible for transfer to a
weaning unit on 36% of occasions. A five-bed unit for
unit D would have a bed occupancy of 48.6% and refusal
rate for new admissions of 3%.
To take account of the effect of patients becoming
unstable once transferred to a weaning unit, the model-
ling exercise was repeated. In this model, those patients
who deteriorated and required cardiovascular support in
units C and D, or renal and cardiovascular support in
models A and B, were assumed to have been transferred
out of the weaning unit and readmitted to the ICU on
the first day of requiring organ support. For reasons of
simplicity, once a patient was readmitted to the ICU,
they were no longer eligible for transfer back to the
weaning unit. The effect of this reduction in weaning
unit bed occupancy and refusal rates is represented in
Figure 2 using broken lines.
The potential cost saving gained from transferring
patients to a weaning unit was modelled accounting for
a limited bed capacity by varying unit capacity from one
to eight beds (Figure 3). For unit D, a three-bed unit
offers the highest cost saving of around £344,000
(€418,000) per year. Staffing a five-bed unit would no
longer create a net saving. Instead, there would be a net
cost of £35,000 (€43,000) per year. Once unstable
patients who are transferred back to the ICU are taken
into consideration, establishing unit D with four beds no
l o n g e rh a sa na s s o c i a t e dc o s ts a v i n g( n e tc o s t£ 3 2 , 0 0 0
(€39,000) per year; Figure 3 broken line). The results of
the sensitivity analysis, which was undertaken by varying
the cost of a weaning unit bed from 50% to 100% of the
cost of an ICU bed, are available in the Additional file 1
(Figures S1 and S2). It showed that once a weaning unit
bed reached 70% of the cost of an ICU bed, a three-bed
unit would no longer yield a cost saving for unit A.
Discussion
We found the incidence of PMV was 4.4 per 100 ICU
admissions or 6.3 per 100 ventilated admissions in a UK
health care administrative region serving a population of
900,000. These patients spent a mean of 37 days in the ICU
and utilised 29% of all ICU bed days. When we modelled
the potential impact of establishing a regional weaning unit
we found that 8 to 10% of ICU beds might be vacated, and
that there was potential for considerable cost savings
(£344,000 (€418,000) per annum in the best scenario).
Table 3 Measuring incidence of PMV using different numerators and denominators
Time period Numerator and denominator n Incidence
(per 100 admissions)
95% CI
2002-2006 countPMV 349 4.4 4.0 to 4.9
ICUtotal 7,848
2002-2006 countPMV 349 6.3 5.7 to 7.0
ICUvent 5,552
2005-2006 consecPMV 126 3.7 3.1 to 4.4
ICUtotal 3,442
2005-2006 countPMV 135 3.9 3.3 to 4.6
ICUtotal 3,442
CI, confidence interval; ICUtotal, all ICU admissions; ICUvent, ICU admissions requiring mechanical ventilation; PMV, prolonged mechanical ventilation. For
definitions of countPMV and consecPMV see text.
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The major strength of our study was the inclusion of
95% of all ICU admissions in the region over the study
period, which minimised selection bias. Other studies
have described a subpopulation of PMV patients follow-
i n gt r a n s f e rt oaw e a n i n gu n i t[ 1 5 ] ,o rw e r eu n a b l et o
report characteristics of excluded patients [4]. We were
also able to undertake a range of sensitivity analyses
based on different definitions and inclusion of cohorts
with uncertain PMV status. These analyses did not
show clinically important variations in our estimates of
incidence, suggesting they were accurate. Two groups of
patients cared for in specific clinical areas were excluded
from our study cohort because these areas did not sub-
mit data to the SICSAG database. Although most
patients with neurological injury who required PMV
were included in the study cohort, a small number who
received ongoing invasive ventilatory support in the
neurosurgical high dependency unit had this period of
ventilation excluded. In addition, any patients ventilated
in cardiothoracic ICU were excluded. Studies reporting
PMV rates following cardiac surgery use a shorter per-
iod of ventilation to define PMV, making a comparison
difficult with our findings. Two UK studies reported
PMV rates of 5.5% (ventilation >48 hours) [16] and 2.6%
(ventilation >96 hours) [17] in these patients. Therefore,
although the patients are few in number, this could
have resulted in a small underestimation of the overall
regional incidence rate.
There are a number of limitations to our modelling
exercise. The retrospective nature of our study meant
that data relating to ventilatory modes, sedation prac-
tice, and weaning methods were not available. Advances
in clinical practice, such as daily sedation breaks [18],
spontaneous breathing trials [19], and weaning protocols
[20] may help to reduce the length of MV and poten-
tially reduce the need for establishing a weaning unit.
We did not take the potential impact of a weaning unit
on outcomes into account, for example, reduced dura-
tion of MV or improved mortality. A reduction in MV
duration would further improve net cost savings and
decrease patient refusals. In addition, we assumed
patients would only be transferred after 21 days,
whereas in practice transfer might occur at an earlier
stage if appropriate, and according to bed pressures.
These factors are difficult to adjust for in a modelling
Table 4 Characteristics and outcomes of PMV patients eligible for four different models of weaning units
Unit A
(n = 101)
Unit B
(n = 113)
Unit C
(n = 110)
Unit D
(n = 117)
Weaning unit description No vasoactive treatment
or RRT for 7 days
No vasoactive treatment
or RRT for 2 days
No vasoactive
treatment
for 7 days
No vasoactive
treatment
for 2 days
Age (mean (SD)) 59 (15) 58 (16) 59 (16) 58 (16)
Sex n (%) female 45 (45) 48 (43) 48 (44) 50 (43)
Surgical status n (%)
Elective 2 (2) 2 (2) 2 (2) 2 (2)
Emergency 11 (11) 12 (11) 13 (12) 13 (11)
Non-surgical 88 (87) 99 (88) 95 (86) 102 (87)
APACHE II score (mean (SD))
a 20.7 (7.0) 20.7 (7.0) 21.0 (6.9) 20.9 (7.0)
Tracheostomy on reaching eligibility for unit; n
(%)
94 (93) 102 (90) 102 (93) 106 (91)
Length of ICU stay after reaching eligibility (days)
Mean (SD) 14.9 (13.4) 14.9 (13.9) 14.9 (13.5) 15.3 (14.0)
Median (IQR) 11 (6 to 22) 11 (5 to 22) 11 (5 to 22) 11 (5 to 23)
Days ventilated after reaching eligibility
Mean (SD) 11.3 (11.8) 11.6 (12.2) 11.5 (11.9) 12.0 (12.2)
Median (IQR) 7 (3 to 17) 7 (3 to 17) 7 (3 to 17) 8 (4 to 17)
Proportion of funded ICU bed-days used by
population after reaching eligibility
8.1% 9.1% 8.9% 9.7%
Possible readmissions to ICU per year n (%)
b 15 (15) 21 (19) 17 (16) 21 (18)
Mortality at ICU discharge n (%) 14 (14) 19 (17) 19 (17) 22 (19)
Mortality at final hospital discharge n (%)
c 29 (32) 35 (34) 34 (34) 38 (36)
an for APACHE II score: n = 88, n = 97, n = 96, n = 101;
bpatients who would be transferred out of the weaning unit due to clinical instability, either requiring
vasoactive therapy or RRT (units A and B) or vasoactive therapy alone (units C and D);
cn for mortality at final hospital discharge: n = 91, n = 102, n = 99, n = 106
for units A to D, respectively.
APACHE, Acute Physiology and Chronic Health Evaluation; IQR, interquartile range; PMV, prolonged mechanical ventilation; RRT, renal replacement therapy; SD,
standard deviation.
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Page 7 of 10exercise, but in general would probably improve the effi-
ciency of resource use. The method of costing health
care in the UK is difficult to generalise to other health
care systems, in part because costs are allocated using a
‘top-down’ approach rather than a per item ‘bottom-up’
approach [21]. Our estimates of cost included the
assumption that both occupied and unoccupied weaning
unit beds incurred similar costs, and we also did not
consider the potential for transfer of suitable patients
prior to 21 days of MV. These factors mean we have
probably underestimated potential cost savings, although
we did not include the capital costs associated with set-
ting up a weaning unit. Despite this, our models are the
first to use high-quality clinical data and consider differ-
ent entry criteria, including adjustment for clinical dete-
rioration. We also evaluated bed occupancy and patient
refusal rates, which has not previously been undertaken.
PMV epidemiology
Incidence estimates are influenced strongly by the
denominator utilised, especially for critical care popula-
tions for which case-mix is dependent on health care
organisation. The most externally valid denominator is
probably patients who require MV in the ICU. Our data
suggest a PMV incidence of 6.3 per 100 ventilated
ICU patients in a typical UK health board region (or
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Page 8 of 10equivalent) for this population. Few studies of PMV
incidence have been published and variations in both
denominator and numerator definitions make direct
comparison with our study difficult. Using the consen-
sus definition of 21 days or longer of MV, a single-cen-
tre Argentinean study reported a PMV incidence of 14.3
per 100 ICU admissions [22], which is considerably
greater than our cohort. Using a PMV definition of 21
days or longer of MV and a denominator of patients
ventilated for 48 hours or longer, a prospective study
b a s e di nas i n g l eU Sc e n t r ef o u n dt h a t1 4 . 0p e r1 0 0
patients required PMV [23]. This compares with a rate
of 9.6 per 100 patients using similar definitions for
numerator and denominator in our cohort (data not
shown). A multicentre population based study in the US
reported an incidence of PMV of 7.7 per 100 ventilated
ICU admissions [24]. However, the numerator was
defined as four days or longer ventilated with a tra-
cheostomy and the denominator excluded elective surgi-
cal patients ventilated for less than 24 hours. Only one
other UK study has reported PMV frequency. The inci-
dence of stable PMV (≥14 days ventilated) patients who
fulfilled criteria for a weaning unit was 2.5 per 100 ICU
admissions [4]. Our data provide a number of measures
of population incidence to improve generalisability of
the findings.
The overall ICU and hospital mortality rates for the
PMV cohort of 26% and 40% are consistent with severe
critical illness. The higher death rate in the PMV cohort
compared with the non-PMV cohort is likely related to
the ongoing burden of chronic critical illness experienced
by these patients [23]. Despite this, we found that 83% of
PMV patients who were discharged alive from the ICU
survived to hospital discharge. Direct comparison with
published outcomes from other studies is difficult because
most published cohorts had different entry criteria or were
selected by admission to a weaning unit [25-29].
A high proportion of patients were discharged to their
own residence from the acute hospital, suggesting that
rehabilitation is occurring primarily in the acute envir-
onment and/or that patients are discharged with signifi-
cant ongoing rehabilitation requirements. A recent UK
guideline has highlighted the need to improve rehabilita-
tion following critical illness [13]. Establishing dedicated
rehabilitation facilities may have the benefit of reducing
hospital stay and improving patient outcomes.
Weaning unit modelling
Our modelling suggested that a three- or four-bed wean-
ing unit was the most cost-efficient for our region. In
practice it is likely that admission criteria might include
patients from each of the four scenarios, with a key prac-
tical consideration being whether RRT in the form of
intermittent haemodialysis would be provided in the unit.
A geographically closer weaning unit would make provi-
sion of RRT or readmission to the ICU in the event of
clinical deterioration more feasible. Only one other study
has modelled a weaning unit in the UK. Robson et al. [4]
used 14 days of ventilation rather than 21 days as the cri-
terion for eligibility and required seven days of clinical
stability prior to transfer. They found that 6.0% of ICU
beds in their region were occupied by patients eligible for
their weaning unit. Despite the limitations of modelling,
our data suggest that a weaning unit could reduce the
cost of providing critical care in our region if the equiva-
lent number of acute ICU beds were reduced.
Further research is needed to evaluate the effect of
establishing a weaning unit on patient-centred outcomes
along with a more detailed economic evaluation. To
date, published reports from US centres support possi-
ble improvements in some outcomes [30,31], and a
reduction in costs [31].
Conclusions
One in every 16 ventilated patients requires PMV in our
region and this group use a substantial amount of health
care resources. Establishing a weaning unit would
potentially reduce acute bed occupancy by 8 to 10% and
could reduce overall treatment costs. Restructuring the
current configuration of critical care services to intro-
duce weaning units should be considered if the expected
increase in PMV incidence occurs.
Key messages
￿ The incidence of PMV in a health care region of
the UK is 4.4 per 100 ICU admissions and 6.3 per
100 ventilated ICU admissions.
￿ Patients requiring PMV utilise almost one-third of
all ICU bed days available.
￿ Establishing a weaning facility on a regional basis
could reduce acute ICU bed occupancy by 10% and
reduce overall health care costs associated with
treating critically ill patients.
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